Melissa N Womble1, Jamie McAllister-Deitrick2, Gregory F Marchetti3, Erin Reynolds4, Michael W Collins5, R J Elbin6, Anthony P Kontos5. 1. Inova Sports Medicine Concussion Program, Fairfax, Virginia. 2. Department of Kinesiology, Coastal Carolina University, Conway, South Carolina. 3. Department of Physical Therapy, Rangos School of Health Sciences, Duquesne University, Pittsburgh, Pennsylvania. 4. Baylor Scott & White Sports Therapy & Research, Sports Concussion Center, Frisco, Texas. 5. Department of Orthopaedic Surgery, UPMC Sports Medicine Concussion Program, University of Pittsburgh, Pittsburgh, Pennsylvania; and. 6. Department of Health, Human Performance and Recreation, Office for Sport Concussion Research, University of Arkansas, Fayetteville, Arkansas.
Abstract
OBJECTIVE: To investigate the association between risk factors and vestibular-oculomotor outcomes after sport-related concussion (SRC). STUDY DESIGN: Cross-sectional study of patients seen 5.7 ± 5.4 days (range 0-30 days) after injury. SETTING: Specialty clinic. PARTICIPANTS: Eighty-five athletes (50 male athletes and 35 female athletes) aged 14.1 ± 2.8 years (range 9-24 years) seeking clinical care for SRC. INTERVENTIONS: Participants completed a clinical interview, history questionnaire, symptom inventory, and vestibular/ocularmotor screening (VOMS). Chi-square tests with odds ratios and diagnostic accuracy were used to examine the association between risk factors and VOMS outcomes. MAIN OUTCOME MEASURES: The VOMS. RESULTS: Female sex (χ2 = 4.9, P = 0.03), on-field dizziness (χ2 = 7.1, P = 0.008), fogginess (χ2 = 10.3, P = 0.001), and post-traumatic migraine (PTM) symptoms including headache (χ2 = 16.7, P = 0.001), nausea (χ2 = 10.9, P = 0.001), light sensitivity (χ2 = 14.9, P = 0.001), and noise sensitivity (χ2 = 8.7, P = 0.003) were associated with presence of one or more postconcussion VOMS score above clinical cutoff. On-field dizziness (χ2 = 3.8, P = 0.05), fogginess (χ2 = 7.9, P = 0.005), and PTM-like symptoms including nausea (χ2 = 9.0, P = 0.003) and noise sensitivity (χ2 = 7.2, P = 0.007) were associated with obtaining a postconcussion near-point convergence (NPC) distance cutoff >5 cm. The likelihood ratios were 5.93 and 5.14 for VOMS symptoms and NPC distance, respectively. CONCLUSIONS: Female sex, on-field dizziness, fogginess, and PTM symptoms were predictive of experiencing vestibular-oculomotor symptoms/impairment after SRC.
OBJECTIVE: To investigate the association between risk factors and vestibular-oculomotor outcomes after sport-related concussion (SRC). STUDY DESIGN: Cross-sectional study of patients seen 5.7 ± 5.4 days (range 0-30 days) after injury. SETTING: Specialty clinic. PARTICIPANTS: Eighty-five athletes (50 male athletes and 35 female athletes) aged 14.1 ± 2.8 years (range 9-24 years) seeking clinical care for SRC. INTERVENTIONS: Participants completed a clinical interview, history questionnaire, symptom inventory, and vestibular/ocularmotor screening (VOMS). Chi-square tests with odds ratios and diagnostic accuracy were used to examine the association between risk factors and VOMS outcomes. MAIN OUTCOME MEASURES: The VOMS. RESULTS: Female sex (χ2 = 4.9, P = 0.03), on-field dizziness (χ2 = 7.1, P = 0.008), fogginess (χ2 = 10.3, P = 0.001), and post-traumatic migraine (PTM) symptoms including headache (χ2 = 16.7, P = 0.001), nausea (χ2 = 10.9, P = 0.001), light sensitivity (χ2 = 14.9, P = 0.001), and noise sensitivity (χ2 = 8.7, P = 0.003) were associated with presence of one or more postconcussion VOMS score above clinical cutoff. On-field dizziness (χ2 = 3.8, P = 0.05), fogginess (χ2 = 7.9, P = 0.005), and PTM-like symptoms including nausea (χ2 = 9.0, P = 0.003) and noise sensitivity (χ2 = 7.2, P = 0.007) were associated with obtaining a postconcussion near-point convergence (NPC) distance cutoff >5 cm. The likelihood ratios were 5.93 and 5.14 for VOMS symptoms and NPC distance, respectively. CONCLUSIONS: Female sex, on-field dizziness, fogginess, and PTM symptoms were predictive of experiencing vestibular-oculomotor symptoms/impairment after SRC.
Authors: R J Elbin; Tracey Covassin; Luke Henry; Diana J Whalen; Jennine Wedge; Anthony P Kontos Journal: Transl Stroke Res Date: 2012-12-21 Impact factor: 6.829
Authors: Paul McCrory; Willem H Meeuwisse; Mark Aubry; Bob Cantu; Jirí Dvorák; Ruben J Echemendia; Lars Engebretsen; Karen Johnston; Jeffrey S Kutcher; Martin Raftery; Allen Sills; Brian W Benson; Gavin A Davis; Richard G Ellenbogen; Kevin Guskiewicz; Stanley A Herring; Grant L Iverson; Barry D Jordan; James Kissick; Michael McCrea; Andrew S McIntosh; David Maddocks; Michael Makdissi; Laura Purcell; Margot Putukian; Kathryn Schneider; Charles H Tator; Michael Turner Journal: Br J Sports Med Date: 2013-04 Impact factor: 13.800
Authors: Donna K Broshek; Tanya Kaushik; Jason R Freeman; David Erlanger; Frank Webbe; Jeffrey T Barth Journal: J Neurosurg Date: 2005-05 Impact factor: 5.115
Authors: Anne Mucha; Michael W Collins; R J Elbin; Joseph M Furman; Cara Troutman-Enseki; Ryan M DeWolf; Greg Marchetti; Anthony P Kontos Journal: Am J Sports Med Date: 2014-08-08 Impact factor: 6.202
Authors: Mark R Lovell; Grant L Iverson; Michael W Collins; Kenneth Podell; Karen M Johnston; Dustin Pardini; Jamie Pardini; John Norwig; Joseph C Maroon Journal: Appl Neuropsychol Date: 2006
Authors: Anthony P Kontos; R J Elbin; Brian Lau; Steven Simensky; Brin Freund; Jonathan French; Michael W Collins Journal: Am J Sports Med Date: 2013-05-22 Impact factor: 6.202
Authors: Christopher P Tomczyk; Morgan Anderson; Kyle M Petit; Jennifer L Savage; Tracey Covassin Journal: J Athl Train Date: 2021-12-01 Impact factor: 2.860
Authors: Shawn R Eagle; Anthony P Kontos; Micky W Collins; Chris Connaboy; Shawn D Flanagan Journal: J Athl Train Date: 2021-02-04 Impact factor: 2.860